Analysis of Oncogene Amplification and C-Myc Overexpression in Human Ovarian Cancer
人卵巢癌癌基因扩增和 C-Myc 过表达分析
基本信息
- 批准号:01571283
- 负责人:
- 金额:$ 0.77万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1989
- 资助国家:日本
- 起止时间:1989 至 1990
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Amplification and expression of oncogenes were investigated in 55 cases of human ovarian cancer tissues. Gene amplificaion of unknown nature was screened by in-gel renaturation assay and amplification of the c-myc, Ki-ras and neu oncogenes were determined by Southern blot hybridization. No significant gene amplification was found in all the cases. By Northern hybridization assay, the c-myc gene was overexpressed in 29 cases (52.7%) whereas either k-ras or neu was not.The overexpression more than 3-fold of the c-myc gene was significant in serous cystadenocarcinoma and endometrioid carcinoma tissues compared with other histological types of tumor. Immunohistochemistry and in-situ hybridization revealed that tumor cells overexpressed both the c-myc gene and the protein.Although the expression level was not related to grading of malignancy, it is suggested that the c-myc gene is involved in early stages of carcinogesis of ovarian tumors.
对55例卵巢癌组织进行了癌基因扩增和表达的研究。用凝胶内复性法筛选未知性质的基因扩增,用Southern印迹杂交法检测c-myc、Ki-ras和neu癌基因的扩增。所有病例均未发现明显的基因扩增。北方杂交结果显示,c-myc基因过表达29例(52.7%),而k-ras和neu基因均不表达,其中浆液性囊腺癌和浆液性囊样癌的c-myc基因过表达率明显高于其他组织学类型。免疫组化和原位杂交结果显示,c-myc基因及其蛋白在卵巢肿瘤细胞中均呈高表达,其表达水平与卵巢肿瘤的恶性程度无关,但提示c-myc基因参与了卵巢肿瘤的早期癌变过程。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fukumoto,M.et al.: "Analysis of Gene Amplification in Human Tumor Cells by Inーgel DNA Renaturation Assay." Acta Heamatol.Jpn.52. 1463-1470 (1989)
Fukumoto, M. 等人:“通过 Ingel DNA 复性测定分析人类肿瘤细胞中的基因扩增。Acta Heamatol.Jpn.52 (1989)”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fukumoto,M.& Midorikawa,O.: "Molecular Biology of Cancer Genes" ed.by Sluyser,M.(Ellis Horwood Ltd.,London), (1990)
福本,M.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
福本 学: "発癌の分子遺伝学" 日本産科婦人科熊本地方部会誌. 34. 93-99 (1990)
Manabu Fukumoto:“致癌的分子遗传学”日本妇产科熊本区杂志 34. 93-99 (1990)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
福本学: "癌化における遺伝子増幅" Medical Immunology. 18. 687-695 (1989)
Manabu Fukumoto:“癌化中的基因扩增”医学免疫学 18. 687-695 (1989)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fukumoto,M.et al.: "Association of Kiーras with Amplified DNA Sequences,Detection in Human Ovarian Carcinoma by a Modified Inーgel Renaturation Assay." Cancer Res.49. 1693-1697 (1989)
Fukumoto, M. 等人:“Kiras 与扩增 DNA 序列的关联,通过改良的 Ingel 复性测定检测人类卵巢癌。”49. 1693-1697 (1989)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUKUMOTO Manabu其他文献
FUKUMOTO Manabu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUKUMOTO Manabu', 18)}}的其他基金
Development of a novel MRI contrast medium toward detection of hypoxic lesions and quantification of partial oxygen pressure
开发一种新型 MRI 造影剂,用于检测缺氧病变和量化氧分压
- 批准号:
23659197 - 财政年份:2011
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular Epidemiological Analysis of Liver and Lung Cancers of Mayak Workers in Russia and Thorotrast Patients in Japan
俄罗斯玛雅克工人和日本胸透患者肝癌和肺癌的分子流行病学分析
- 批准号:
15406010 - 财政年份:2003
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular genetic mechanism of alpha-parficle induced human cancers : Analysis of liver carcinogenesis in Thorotrast patients.
α颗粒诱发人类癌症的分子遗传机制:Thorotrast患者肝癌发生的分析。
- 批准号:
14390006 - 财政年份:2002
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Evaluation of Indication for Liver Transplantation in Primary Liver Cancers : Focused on Analysis of Multicentric Liver Cancers and Relapse of Prediction.
原发性肝癌肝移植指征的评估:重点分析多中心肝癌和复发预测。
- 批准号:
10470048 - 财政年份:1998
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
An Attempt to Clone Amplified Genes which are Overexpressed
克隆过度表达的扩增基因的尝试
- 批准号:
05454179 - 财政年份:1993
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Analysis of Gene Amplification in Association with Carcinogenesis
基因扩增与癌变相关的分析
- 批准号:
03454169 - 财政年份:1991
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
An optical lipid sensor for the detection of ovarian cancer biomarkers in blood
用于检测血液中卵巢癌生物标志物的光学脂质传感器
- 批准号:
24K17704 - 财政年份:2024
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring immune checkpoint pathways as novel therapeutic targets in ovarian cancer
探索免疫检查点通路作为卵巢癌的新治疗靶点
- 批准号:
22KK0268 - 财政年份:2023
- 资助金额:
$ 0.77万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Exploring ATR and PARP Inhibitors for Ovarian Cancer Management: An Innovative Approach
探索 ATR 和 PARP 抑制剂用于卵巢癌治疗:一种创新方法
- 批准号:
494635 - 财政年份:2023
- 资助金额:
$ 0.77万 - 项目类别:
Operating Grants
Decoding the impact of single cell mutational processes in triple negative breast cancer and high grade serous ovarian cancer
解读单细胞突变过程对三阴性乳腺癌和高级别浆液性卵巢癌的影响
- 批准号:
477662 - 财政年份:2023
- 资助金额:
$ 0.77万 - 项目类别:
Operating Grants
Combination of plasma gelsolin with radiological imaging for prognostication of ovarian cancer
血浆凝溶胶蛋白与放射成像相结合用于卵巢癌的预后
- 批准号:
495885 - 财政年份:2023
- 资助金额:
$ 0.77万 - 项目类别:
Miscellaneous Programs
Lipid molecules regulate the prolifetation of ovarian cancer via LSR
脂质分子通过LSR调节卵巢癌的增殖
- 批准号:
23K19506 - 财政年份:2023
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer
改造 T 细胞以克服抑制性受体信号,这些信号限制了过继性细胞疗法对卵巢癌的疗效
- 批准号:
10526155 - 财政年份:2023
- 资助金额:
$ 0.77万 - 项目类别:
Experiences of Discrimination, Dysbiosis, and Racial Disparities in Ovarian Cancer
卵巢癌中的歧视、生态失调和种族差异的经历
- 批准号:
10371537 - 财政年份:2023
- 资助金额:
$ 0.77万 - 项目类别:
Signaling basis of senescence-associated secretory phenotype and its implications in epithelial ovarian cancer
衰老相关分泌表型的信号基础及其在上皮性卵巢癌中的意义
- 批准号:
10731600 - 财政年份:2023
- 资助金额:
$ 0.77万 - 项目类别:
Role of miR-195 in Chemo-Resistant Ovarian Cancer
miR-195 在化疗耐药性卵巢癌中的作用
- 批准号:
10640540 - 财政年份:2023
- 资助金额:
$ 0.77万 - 项目类别: